Certification Programme in Fundamentals of Health Economics and Outcomes Research
A self-paced, online programme that gives students, pharmacists, physicians and industry professionals the working knowledge of HEOR that payers, HTA bodies and pharma employers now expect.
Built by consultants who do this work every day
HEOR is an increasingly important domain as rising healthcare costs challenge every health system. Whether you are a student, a graduate or a professional moving into market access, this certification is the preliminary requisite to enhance your knowledge and skills — taught by the same team that delivers HTA submissions and RWE studies for global pharma.
Module 1: Health Economics and Outcomes Research
Cost estimation, ICER, HRQoL and utility measures, discounting, transferability, economic evaluation in trials and pharmacoeconomic guidelines.
Module 2: Health Technology Assessment and Real World Evidence
HTA fundamentals, RWE scope and sources, comparative effectiveness, retrospective and observational studies, big data, bias and regulatory perspectives.
Module 3: Patient Reported Outcomes
PRO fundamentals, item response theory, content validity, psychometrics, patient preference methods, PROs in trials and label claims.
Module 4: Modelling and Simulation
Conceptual model development, decision trees, Markov models, discrete-event simulation, Bayesian analysis, health-state utilities, budget impact and visualisation.
Module 5: Market Access, Pricing and Reimbursement
Pricing across pharma, biotech and devices, reimbursement systems, MCDA, patient access schemes, formulary development, value frameworks and value-based pricing.
Special Module 1: Healthcare Value Access & Societal Impact
NewPricing strategy and value-based pricing, market access and reimbursement pathways, advanced therapies and orphan populations, patient centricity and advocacy, preference science, value-based payment models, medical affairs and evidence-led value planning, digital health and device access, policy, ethics and data sharing, equity and the societal perspective.
Special Module 2: Advanced Evidence Generation: RWE, Analytics & Emerging Technologies
NewRegulatory-grade RWE frameworks, RWD sources (EHRs, registries, networks), pragmatic and hybrid designs, external and synthetic controls, scoping, rapid and living reviews, search strategy and QA, indirect comparisons and meta-analysis, bias and certainty assessment, transparent reporting, analytics and visualisation, and AI and automation in evidence generation.
What certified professionals say
“Easily accessible and affords the learner a complete, abbreviated view of all the contemporary topics including HRQoL, discounting, DES and a host of key topics. A fantastic foundation.”
“The courses were extremely interesting, comprehensive and detailed. The tests allowed me to assess my knowledge regularly and identify areas that needed review.”
“I speak confidently within my organisation when it comes to pharmacoeconomics and health outcomes. MarksMan enabled me to speak my clients' language.”
“Rich with scientific and research approach. I earned a lot of knowledge in HTA fundamentals, modelling and simulation, market access and pricing, and patient-reported outcomes.”
“A comprehensive course encompassing cost minimisation, cost utility, budget impact, decision tree and Markov modelling and market access. A lighthouse for anyone pursuing a career in HEOR.”
“Covered all major topics focusing on one concept at a time. Relevant topics and mock tests to assess learning are just a few of the reasons to enrol.”
Ready to build your HEOR foundation?
Enrol online in minutes. For group enrolments or questions, reach the Academy team directly.